Archive

ECCO 2017: Highlights

If you missed ECCO this year, or if you attended, but didn’t get to see everything you’d hoped to, listen to the key highlights from Professor Séverine Vermeire… read more.

Vulnerable patients: burning questions in IBD

An interesting session at ECCO dealt with the patients for whom there is sparce data to guide their treatment – experts in the field gave their guidance to… read more.

New compounds in the treatment of IBD (ECCO 2017)

Never before in the history of IBD have there been so many promising compounds in the pipeline. In a scientific session dedicated to new compounds, leading investigators discussed… read more.

Clinical trials vs real life

Dr Filip Baert (Roeselare, Belgium) gives a summary of his session on trial endpoints vs therapeutic objectives. he also discusses the role of ECCO in improving the data generated in… read more.

Predicting disease years before diagnosis

Predicting disease years before diagnosis is a passion for Professor Jean-Frederic Colombel (Icahn School of Medicine at Mount Sinai, NY, USA). Here he discusses 2 studies presented at… read more.

ECCO 2016: Professor Stefan Schreiber (Kiel, Germany) discusses some of the issues in managing Crohn’s disease.

In it for the long haul – managing the complexity of Crohn’s disease by Maria Dalby Michael Kamm (Melbourne, Australia), Remo Panaccione (Alberta, Canada) and Stefan Schreiber (Kiel,… read more.

ECCO 2016: Professor Stefan Schreiber (Kiel, Germany) discusses some of the issues in managing Crohn's disease.

In it for the long haul – managing the complexity of Crohn’s disease by Maria Dalby Michael Kamm (Melbourne, Australia), Remo Panaccione (Alberta, Canada) and Stefan Schreiber (Kiel,… read more.

ECCO 2016: Marian O’Connor (Harrow, UK) and Helen Terry (CCUK) discuss the importance of the IBD nurse, how the role has changed, how the UK had led the way and what the future holds for IBD nurses.

The future is now – importance of the IBD nurse in patient care. by Maria Dalby Marian O’Connor (St Mark’s Hospital, London, UK ), Silvio Danese (Milan, Italy)… read more.

ECCO 2016: Professor David Rubin (Chicago, USA), Dr Charlie Lees (Edinburgh, UK) and Dr Peter Irving (London, UK) discuss when to cycle biologics within class and when to switch classes for patients failing on anti-TNF therapy.

ECCO 2016: Dr Ailsa Hart (St Mark’s Hospital IBD Unit, Harrow, UK) discusses the issues raised at this year’s ECCO around cost effectiveness in IBD.

ECCO 2016: Helen Terry (CCUK Director of Policy, Research and Public Affairs, UK) discusses the impact on IBD care of involving patients in patient panels.

ECCO 2016: Specialists gathered to discuss new data and current issues and solutions in IBD. Professor David Rubin (Chicago, USA), ECCO President Professor Séverine Vermeire (Leuven, Belgium), Professor Stefan Schreiber (Kiel, Germany) and Dr Peter Irving (London, UK) took time out to discuss with IBD.Update what they are excited about what’s coming up in the near future for patients with IBD.